Feedback Share Discussion Threads

[lr2] 23/8/2021 11:52

Morning Digger, doing OK thanks. All very quiet here at present. Someone modified the following Bleepa web page on the 18th. Think they added this line, "Bleepa has also created a source of data that can be interrogated to support links between patient treatment and outcomes." That's about it for now.

[digger2779] 23/8/2021 11:31

Morning all. How are we holding up? Better than the share price I hope. Scrolled down the page too quickly and thought we had a million buy at first!!!!

[ydderf] 19/8/2021 10:59

Ged5 and LR2 - do you realise you are embarrassing yourselves with your ad hominem puerileisms ? (asking for a friend)

[ged5] 19/8/2021 10:08

Too true, Gilou!

Five weeks tomorrow since the last contract was announced, so Friday was a good announcement day. We could do with a few more.

Papworth, Pennine, other NHS trust or Private? India, more veterinary or other sector?

I don't care which, although I would prefer all.

Didn't like it, did he LR2?

[gilou9] 19/8/2021 09:58

The CEO having a holding of shares and better still a large holding would of course be a vote of confidence.

What is however more important he starts delivering contracts that have some decent sized revenues. We would then see a sharp upward movement in the share price

[lr2] 19/8/2021 09:47

Ouch! Very true but Ouch!

[ged5] 19/8/2021 09:40

ydderF 19 Aug '21 - 09:34 - 8411 of 8412(premium)
(Filtered)0 0 0

Perhaps if TO owned shares he could then try to inflate the sp, sell his shares then have a placing.

Now what sort of crook would do that?

[ged5] 19/8/2021 09:34

I agree with what you're saying, Yump.

The continual downward path of the share price has made me look again at why I'm here. Do I make the classic PI mistake of selling at or near the bottom? Do I add?

Since I'm not overweight here I've decided to do neither for the time being. I expect the share price to drift further but if the right news is announced this could rebound sharply.

Checking the website, it is littered with comments such as this:

"It’s a testament to what can be delivered, in terms of a really great, viable product, when these sorts of teams get together, understand each other, have a really good working relationship and are able to develop something in collaboration. Now Bleepa is at a point where it speaks for itself.”
Dr Nevan Meghani, Respiratory Registrar

It really does make one wonder why there hasn't been a greater uptake of Bleepa. It also makes one wonder why the CEO isn't loaded up with shares. Now come on Tom, earn that salary of yours.

[ydderf] 19/8/2021 09:34

Whatever the prospects for Bleepa, this decline in the share price doesn't appear to be driven by fundamentals, instead a persistent seller in the absence of natural buying seems to be causing the decline. If the seller clears, the share price will presumably recover in the short term.

However the negative base case remains, i.e. no real revenue, cash (extrapolating from published data) falling, no evidence of a commercial product after two and a bit years of trying to get traction.

The tail wind of benevolent indiscriminating conditions in the AIM market also appear to be ending - without having benefitted Feedback incidentally - Maybe TO will return from his vacation (no idea if he is on one, but let's hope that is the reason for radio silence) and issue another interview about another contract in a parallel universe, sorry I mean market, and provoke a feeding frenzy here...

....into which another placing can be launched

[lr2] 17/8/2021 19:42

CT texture analysis of tonsil cancer: Discrimination from normal palatine tonsils

[digger2779] 17/8/2021 15:50

Another solid performance today, jeez. It's about time young Tom gave us an update on where they are with any contract negotiations. Leaving us hanging with watch this space type innuendos aren't cutting it.

[davwal] 16/8/2021 19:46

Okay, thanks Trev..

[hedgehog 100] 16/8/2021 16:42

13/10/2020 07:00 UK Regulatory (RNS & others) Feedback PLC Final Results LSE:FDBK Feedback Plc
"... Salary Fees Pension Benefits Total
GBP GBP GBP in kind GBP
GBP
Year ended 31 May 2020
-------- ------ --------- -------- -------
Executive Directors
-------- ------ --------- -------- -------
T Oakley (including GBP40,000
performance bonus) 170,000 - - - 170,000 ..."



A salary of £170K. looks to me to be well over the going rate for a very small AIM company CEO ... so why no complaints from LR2?

I bet that his attitude would be very different if it was Trevor Brown.

From the IQAI thread:

Hedgehog 100 9 May '19 - 16:11 - 147 of 6806 Edit 0 0 0
" ... I believe that you are WRONG about Trevor Brown, and that you have been conducting a long, drawn-out campaign against him because of frustration about how you investment in Feeback has been harmed by his FDBK shares sales. But those sales were his right.
I've read some of your obsessive, bitter comments about Trevor Brown, but from my research I have no concerns about him. For example, you suggested that he would take IQAI for an excessive salary. I checked, expecting something of £100K.+, but instead I found it to to £60K., which is perfectly reasonable.
Then look at IQAI's March 2019 convertible loan notes fundraising, over 90% of which was subscribed for by Trevor Brown himself: Trevor Brown could have set the conversion price at the current shareprice then of 1.275p, but he did not: he set it at a premium to that of over 50% (i.e. 2p).
Well done I say on showing such respect to existing shareholders, and integrity.
How many other companies are raising funds, via convertible loan notes or otherwise, at a premium of over 50%?"

[hedgehog 100] 16/8/2021 14:30

Hedgehog 100 29 May '19 - 18:51 - 788 of 8404 Edit 0 0 0
" ... Who would like to predict the price of FDBK's next fundraising?
Current share price 0.725p, market cap. £2.71M.
... IQAI's current market cap. (£1.44M. at 1.2p) ..."

LR2 15 Aug '21 - 18:37 - 8401 of 8404 0 0 0
"There are no faithful believers on RMS, BRH and IQAI either.
Guess what the common denominator is?"


CURRENT S.P.s:
FDBK 0.7p
IQAI 6.875p ... i.e. nearly ten times higher than FDBK.

Enough said I think.

[lr2] 15/8/2021 23:24

He certainly does, Digger. Everyone except the FCA knows what he is all about.

[digger2779] 15/8/2021 20:37

LR2 - saw the shenanigans on BRH. Director selling shares on numerous occasions thus trashing the share price and then having the gall to buy back in on a discounted fund raiser. Needs investigating.

[lr2] 15/8/2021 18:37

There are no faithful believers on RMS, BRH and IQAI either.
Guess what the common denominator is?

[lr2] 13/8/2021 22:58

TexRAD still breaking new ground.

Radiomics-Based Texture Analysis of 68Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With 177Lu-DOTATATE



Conclusion: These preliminary data generate a hypothesis that radiomic analysis of neuroendocrine cancer on 68Ga-DOTATATE PET-CT may be of prognostic value and a valuable addition to the assessment of patients.

[lr2] 13/8/2021 16:33

Manchester, Bury, Oldham, Rochdale everyone's talking about Bleepa digital.

[ducatiman] 13/8/2021 16:16

Did anyone notice this from feedback yesterday:- “ Pennine Acute Hospitals NHS Trust's adoption of #Bleepa.”
I know it’s being trialled at Oldham but adoption!?

[lr2] 13/8/2021 16:09

So nice, isn't it?